Ukpong Bassey Eyo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ukpong Bassey Eyo has a total of 291 co-authors. Here are the top co-authors by number of shared publications:
- Amanda M. Briegel
Carter Immunology Center, University of Virginia, Charlottesville, Virginia
8 shared publications - Anthony B. Rodriguez
Beirne B. Carter Center for Immunology Research, University of Virginia School of Medicine, Charlottesville, VA 22908, USA; Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
8 shared publications - Craig L. Slingluff
Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia, Charlottesville, USA
8 shared publications Katarzyna Stasiak
8 shared publications- Long-Jun Wu
Center for Neuroimmunology and Glial Biology, Institute of Molecular Medicine, University of Texas Health Science Center at Houston , Houston, TX 77030
8 shared publications - Marit Melssen
Immunology, Genetics & Pathology, Uppsala University, Uppsala, Sweden
8 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (12)
Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis
Recent genome-wide association studies have identified numerous Alzheimer’s disease (AD) risk genes enriched in microglia, including Crk-associated substrate (Cas) scaffold protein family member 4 (CASS4), which encodes the adaptor protein CASS4. Despite its strong genetic association with AD, the role of CASS4 in disease remains poorly understood. Here, we show that full-body Cass4 deletion in 5xFAD mice increases amyloid-β (Aβ) deposition, neuronal dystrophy, and cognitive deficits. Since microglia are the predominant brain-resident cells expressing Cass4, we investigated its role in microglial responses to Aβ pathology. Loss of CASS4 impaired microglial mobilization to Aβ plaques and reduced plaque compaction. Phosphoproteomic analysis of purified microglia revealed marked disruption of focal adhesion signaling following Cass4 deletion. Consistent with this, CASS4 deficiency abrogated in vivo microglial recruitment to injury and in vitro wound healing responses, two processes that are centrally orchestrated by focal adhesion biology. Together, these findings identify CASS4 as a critical regulator of microglial function and focal adhesion biology and suggest that CASS4 may represent a therapeutic target for AD.
- 27 October 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (12)
Open AccessAlzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis
Recent genome-wide association studies have identified numerous Alzheimer’s disease (AD) risk genes enriched in microglia, including Crk-associated substrate (Cas) scaffold protein family member 4 (CASS4), which encodes the adaptor protein CASS4. Despite its strong genetic association with AD, the role of CASS4 in disease remains poorly understood. Here, we show that full-body Cass4 deletion in 5xFAD mice increases amyloid-β (Aβ) deposition, neuronal dystrophy, and cognitive deficits. Since microglia are the predominant brain-resident cells expressing Cass4, we investigated its role in microglial responses to Aβ pathology. Loss of CASS4 impaired microglial mobilization to Aβ plaques and reduced plaque compaction. Phosphoproteomic analysis of purified microglia revealed marked disruption of focal adhesion signaling following Cass4 deletion. Consistent with this, CASS4 deficiency abrogated in vivo microglial recruitment to injury and in vitro wound healing responses, two processes that are centrally orchestrated by focal adhesion biology. Together, these findings identify CASS4 as a critical regulator of microglial function and focal adhesion biology and suggest that CASS4 may represent a therapeutic target for AD.
- Open Access
- 25 July 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (8) , 117709
Sex differences in somatosensory circuitry are programmed by developmental microglia-astrocyte interaction
- 25 July 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (8) , 117709
Open AccessSex differences in somatosensory circuitry are programmed by developmental microglia-astrocyte interaction
- Open Access
- 8 June 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Transcriptional analyses identify pericyte-centered signaling programs altered by sex and brain region in Alzheimer’s Disease
Pericytes are critical components of the neurovascular unit (NVU), regulating endothelial cell stability, blood-brain barrier (BBB) integrity, and neuroimmune signaling. Their role in Alzheimer's Disease (AD), particularly regarding sex differences and brain region specificity, remains poorly defined. Using single-nucleus RNA sequencing analysis and cell-cell communication tools (LIANA, Tensor-cell2cell), we characterize pericyte transcriptional and signaling changes across the middle temporal gyrus (MTG) and dorsolateral prefrontal cortex (DLPFC) of AD and non-AD donors stratified by sex. We identify a pericyte-endothelial TGFβ signaling program upregulated in female AD donors specifically in the MTG, and a downregulated estrogen pathway involving pericyte-astrocyte ligand-receptor interactions, supported by increased pericyte-astrocyte separation in spatial transcriptomics. We also identify a microglia-to-pericyte program enriched for hypoxia and p53 pathways that is elevated in both sexes with regional specificity. Our findings implicate pericyte-driven communication as a mechanistic contributor to female-biased AD vulnerability, and support sex- and region-aware approaches in neurodegeneration research.
- 8 June 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessTranscriptional analyses identify pericyte-centered signaling programs altered by sex and brain region in Alzheimer’s Disease
Pericytes are critical components of the neurovascular unit (NVU), regulating endothelial cell stability, blood-brain barrier (BBB) integrity, and neuroimmune signaling. Their role in Alzheimer's Disease (AD), particularly regarding sex differences and brain region specificity, remains poorly defined. Using single-nucleus RNA sequencing analysis and cell-cell communication tools (LIANA, Tensor-cell2cell), we characterize pericyte transcriptional and signaling changes across the middle temporal gyrus (MTG) and dorsolateral prefrontal cortex (DLPFC) of AD and non-AD donors stratified by sex. We identify a pericyte-endothelial TGFβ signaling program upregulated in female AD donors specifically in the MTG, and a downregulated estrogen pathway involving pericyte-astrocyte ligand-receptor interactions, supported by increased pericyte-astrocyte separation in spatial transcriptomics. We also identify a microglia-to-pericyte program enriched for hypoxia and p53 pathways that is elevated in both sexes with regional specificity. Our findings implicate pericyte-driven communication as a mechanistic contributor to female-biased AD vulnerability, and support sex- and region-aware approaches in neurodegeneration research.
- Open Access
Microglia and its P2RY12 Receptors Regulate Seizure Severity
Microglia have emerged as possible regulators of seizures with previous approaches employed being insufficiently selective of microglial-specific contributions. To more definitely determine microglial roles in seizure severity, we used the recently developed genetic microglial-deficient Csf1rΔFIRE/ΔFIRE (FIRE KO) mouse model. In this model, mice lack microglia but retain brain border associated macrophages (BAMs). Using two experimental seizure paradigms with either a chemoconvulsant or electrical stimulation, we confirm that a microglial deficiency exacerbates seizures, reduces survival and facilitates the likelihood of developing spontaneous recurrent seizures, indicating that microglia constrain seizure activity across different seizure paradigms. To gain insights into molecular regulators of seizure severity under microglial regulation, we examined P2RY12 contributions and demonstrate that a loss of microglial P2RY12 increased seizure severity in both global and microglial-specific knockout mice indicating that microglia suppress seizure severity in chemoconvulsive models through P2RY12 signaling. During seizures, P2RY12-deficient microglia displayed altered process complexity, accompanied by increased neuronal activation and reduced inhibitory tone. These results link impaired microglial responses to heightened seizure susceptibility and network excitability. Together, our findings establish microglia as protective regulators of seizure activity and identify P2RY12 signaling as a critical mediator of microglia protective actions.
Open AccessMicroglia and its P2RY12 Receptors Regulate Seizure Severity
Microglia have emerged as possible regulators of seizures with previous approaches employed being insufficiently selective of microglial-specific contributions. To more definitely determine microglial roles in seizure severity, we used the recently developed genetic microglial-deficient Csf1rΔFIRE/ΔFIRE (FIRE KO) mouse model. In this model, mice lack microglia but retain brain border associated macrophages (BAMs). Using two experimental seizure paradigms with either a chemoconvulsant or electrical stimulation, we confirm that a microglial deficiency exacerbates seizures, reduces survival and facilitates the likelihood of developing spontaneous recurrent seizures, indicating that microglia constrain seizure activity across different seizure paradigms. To gain insights into molecular regulators of seizure severity under microglial regulation, we examined P2RY12 contributions and demonstrate that a loss of microglial P2RY12 increased seizure severity in both global and microglial-specific knockout mice indicating that microglia suppress seizure severity in chemoconvulsive models through P2RY12 signaling. During seizures, P2RY12-deficient microglia displayed altered process complexity, accompanied by increased neuronal activation and reduced inhibitory tone. These results link impaired microglial responses to heightened seizure susceptibility and network excitability. Together, our findings establish microglia as protective regulators of seizure activity and identify P2RY12 signaling as a critical mediator of microglia protective actions.
- Open Access
Transcriptional Regulation of Microglial Metabolic and Activation States by P2RY12
Microglia are the resident immune cells of the CNS. Under homeostatic conditions, microglia play critical roles in orchestrating synaptic pruning, debris clearance, and dead cell removal. In disease, they are powerful mediators of neuroinflammation, as they rapidly respond to injury or infection within the CNS by altering their morphology, proliferating, and releasing cytokines and other signaling molecules. Understanding the molecular pathways involved in microglial function is pivotal for advancing neurobiological research and developing effective strategies for CNS disorders. In this context, P2RY12 is a G protein‐coupled receptor (GPCR) that is uniquely enriched in microglia in the parenchyma and a canonical marker of homeostatic, ramified microglia. However, P2RY12 is downregulated in activated microglia and in neurological conditions. The consequences of P2RY12 downregulation in disease‐associated microglia and how they influence microglial activation remain poorly understood. In this study, we apply transcriptional and histological methods to explore the changes to microglia upon a genetic P2RY12 loss. Our findings reveal that P2RY12‐deficient microglia experience alterations in distinct metabolic pathways while preserving overall homeostatic microglial transcriptional identity. Lack of P2RY12 alters signature genes involved in homeostatic iron metabolism. Importantly, the genes encoding proteins in the Glutathione Peroxidase 4 ( Gpx4 )‐Glutathione (GSH) antioxidant pathway related to ferroptosis susceptibility are impaired upon microglial activation with lipopolysaccharide (LPS) treatment. These results highlight the critical role of P2RY12 in regulating microglial immune and metabolic transcriptional responses under both homeostatic and inflammatory conditions, providing insights into its involvement in CNS pathophysiology.
Open AccessTranscriptional Regulation of Microglial Metabolic and Activation States by P2RY12
Microglia are the resident immune cells of the CNS. Under homeostatic conditions, microglia play critical roles in orchestrating synaptic pruning, debris clearance, and dead cell removal. In disease, they are powerful mediators of neuroinflammation, as they rapidly respond to injury or infection within the CNS by altering their morphology, proliferating, and releasing cytokines and other signaling molecules. Understanding the molecular pathways involved in microglial function is pivotal for advancing neurobiological research and developing effective strategies for CNS disorders. In this context, P2RY12 is a G protein‐coupled receptor (GPCR) that is uniquely enriched in microglia in the parenchyma and a canonical marker of homeostatic, ramified microglia. However, P2RY12 is downregulated in activated microglia and in neurological conditions. The consequences of P2RY12 downregulation in disease‐associated microglia and how they influence microglial activation remain poorly understood. In this study, we apply transcriptional and histological methods to explore the changes to microglia upon a genetic P2RY12 loss. Our findings reveal that P2RY12‐deficient microglia experience alterations in distinct metabolic pathways while preserving overall homeostatic microglial transcriptional identity. Lack of P2RY12 alters signature genes involved in homeostatic iron metabolism. Importantly, the genes encoding proteins in the Glutathione Peroxidase 4 ( Gpx4 )‐Glutathione (GSH) antioxidant pathway related to ferroptosis susceptibility are impaired upon microglial activation with lipopolysaccharide (LPS) treatment. These results highlight the critical role of P2RY12 in regulating microglial immune and metabolic transcriptional responses under both homeostatic and inflammatory conditions, providing insights into its involvement in CNS pathophysiology.
- Open Access
Multimodal analysis identifies pericyte-centered signaling programs altered by sex and brain region in Alzheimer’s Disease
Pericytes are critical components of the neurovascular unit (NVU), regulating endothelial cell (EC) stability, blood-brain barrier (BBB) integrity, and neuroimmune signaling. However, their role in Alzheimer’s Disease (AD), particularly in the context of sex differences and brain region specificity, remains poorly defined. Here, we use single-nucleus RNA sequencing (snRNA-seq) to characterize transcriptional and intercellular signaling changes in pericytes across the middle temporal gyrus (MTG) and dorsolateral prefrontal cortex (DLPFC) of the same AD and non-AD donors, stratified by sex. Using LIANA and Tensor-cell2cell, we identify latent communication programs altered in female AD donors, including a pericyte-EC signaling pattern that activates TGFβ via extracellular matrix ligands and is upregulated in the MTG but not the DLPFC. A second communication pattern, downregulated in female AD donors, reveals impaired estrogen pathway signaling through ligand-receptor interactions between pericytes and astrocytes. Supporting this, we observe reduced expression of pericyte-derived neuroligins and increased pericyte-astrocyte separation in a spatial transcriptomic subset. Additionally, we identify a microglia-to-pericyte signaling program conserved across brain regions, enriched for inflammatory pathways including hypoxia and p53, and elevated in both male and female AD donors with regional specificity. This result contrasts with the more sex-and region-specific pericyte signaling programs and suggests parallel mechanisms of NVU disruption between brain regions in AD. Our findings reveal brain region-specific and sex-specific pericyte signaling changes in AD and implicate vascular-, immune-, and synapse-associated pathways in NVU dysfunction. Altogether, the data suggest pericyte-driven communication as a mechanistic contributor to female-biased vulnerability in AD and support the need for sex-aware and region-specific approaches in neurodegeneration research.
Open AccessMultimodal analysis identifies pericyte-centered signaling programs altered by sex and brain region in Alzheimer’s Disease
Pericytes are critical components of the neurovascular unit (NVU), regulating endothelial cell (EC) stability, blood-brain barrier (BBB) integrity, and neuroimmune signaling. However, their role in Alzheimer’s Disease (AD), particularly in the context of sex differences and brain region specificity, remains poorly defined. Here, we use single-nucleus RNA sequencing (snRNA-seq) to characterize transcriptional and intercellular signaling changes in pericytes across the middle temporal gyrus (MTG) and dorsolateral prefrontal cortex (DLPFC) of the same AD and non-AD donors, stratified by sex. Using LIANA and Tensor-cell2cell, we identify latent communication programs altered in female AD donors, including a pericyte-EC signaling pattern that activates TGFβ via extracellular matrix ligands and is upregulated in the MTG but not the DLPFC. A second communication pattern, downregulated in female AD donors, reveals impaired estrogen pathway signaling through ligand-receptor interactions between pericytes and astrocytes. Supporting this, we observe reduced expression of pericyte-derived neuroligins and increased pericyte-astrocyte separation in a spatial transcriptomic subset. Additionally, we identify a microglia-to-pericyte signaling program conserved across brain regions, enriched for inflammatory pathways including hypoxia and p53, and elevated in both male and female AD donors with regional specificity. This result contrasts with the more sex-and region-specific pericyte signaling programs and suggests parallel mechanisms of NVU disruption between brain regions in AD. Our findings reveal brain region-specific and sex-specific pericyte signaling changes in AD and implicate vascular-, immune-, and synapse-associated pathways in NVU dysfunction. Altogether, the data suggest pericyte-driven communication as a mechanistic contributor to female-biased vulnerability in AD and support the need for sex-aware and region-specific approaches in neurodegeneration research.
- Open Access
Transcriptional Regulation of Microglial Metabolic and Activation States by P2RY12
Microglia are the resident immune cells of the CNS. Under homeostatic conditions, Microglia play critical roles orchestrating synaptic pruning, debris clearance and dead cells removals. In disease, they are powerful mediators of neuroinflammation, as they rapidly respond to injury or infection within the CNS by altering their morphology, proliferating, and releasing cytokines and other signaling molecules. Understanding the molecular pathways involved in microglial function is pivotal for advancing neurobiological research and developing effective strategies for CNS disorders. In this context, P2RY12 is a G protein-coupled receptor (GPCR) that is uniquely enriched in microglia in the parenchyma and a canonical marker of homeostatic, ramified microglia. However, P2RY12 is downregulated in activated microglia and in neurological conditions. The consequences of P2RY12 downregulation in disease-associated microglia and how they influence microglial activation remain poorly understood. In this study, we apply transcriptional and histological methods to explore the changes to microglia upon a genetic P2RY12 loss. Our findings reveal that P2RY12-deficient microglia experience alterations in distinct metabolic pathways while preserving overall homeostatic microglial transcriptional identity. Lack of P2RY12 alters signature genes involved in homeostatic iron metabolism. Importantly, the genes encoding proteins in the Glutathione Peroxidase 4 ( Gpx4 )-Glutathione (GSH) antioxidant pathway related to ferroptosis susceptibility are impaired upon microglial activation with lipopolysaccharide (LPS) treatment. These results highlight the critical role of P2RY12 in regulating microglial immune and metabolic transcriptional responses under both homeostatic and inflammatory conditions, providing insights into its involvement in CNS pathophysiology. Proposed Model: At basal condition the transcriptional landscape of P2RY12-deficient microglia suggests that the cell is in a highly demanding metabolic state with increased oxidative phosphorylation and glycolysis as well as augmented expression of ribosomal proteins involved in cytoplasmic translation. Additionally, P2RY12-deficient microglia exhibit heightened expression of key regulators of the antioxidant response, suggesting elevated ROS levels as a consequence of this highly metabolically active and energetically demanding microglial state. Elevated ROS levels might diminish microglial antioxidant reserves thus rendering them more vulnerable to additional oxidative stress pushing the redox balance. When activated by LPS treatment, P2RY12-deficient microglia exhibit an impaired responsiveness of system x c and downstream enzymes involved in GSH mediated antioxidant response that together with LPS induced intracellular iron sequestration(François et al., 2014; S. Liu, Gao, & Zhou, 2022; McCarthy et al., 2018; Sfera et al., 2018; Shin et al., 2018; Urrutia et al., 2013) suggesting that P2RY12-deficient microglia will show increased susceptibility to ferroptosis. It is possible that system x c unresponsiveness in KO microglia results from the upregulation of ribosomal proteins involved in the inhibition of MD2, a negative regulator of p53 DNA binding activity(Daftuar, Zhu, Jacq, & Prives, 2013). In this sense, the repression of p53 inhibition will enhance its function, possibly explaining a suppression of Slc7a11 expression in LPS-activated P2RY12 deficient microglia.
Open AccessTranscriptional Regulation of Microglial Metabolic and Activation States by P2RY12
Microglia are the resident immune cells of the CNS. Under homeostatic conditions, Microglia play critical roles orchestrating synaptic pruning, debris clearance and dead cells removals. In disease, they are powerful mediators of neuroinflammation, as they rapidly respond to injury or infection within the CNS by altering their morphology, proliferating, and releasing cytokines and other signaling molecules. Understanding the molecular pathways involved in microglial function is pivotal for advancing neurobiological research and developing effective strategies for CNS disorders. In this context, P2RY12 is a G protein-coupled receptor (GPCR) that is uniquely enriched in microglia in the parenchyma and a canonical marker of homeostatic, ramified microglia. However, P2RY12 is downregulated in activated microglia and in neurological conditions. The consequences of P2RY12 downregulation in disease-associated microglia and how they influence microglial activation remain poorly understood. In this study, we apply transcriptional and histological methods to explore the changes to microglia upon a genetic P2RY12 loss. Our findings reveal that P2RY12-deficient microglia experience alterations in distinct metabolic pathways while preserving overall homeostatic microglial transcriptional identity. Lack of P2RY12 alters signature genes involved in homeostatic iron metabolism. Importantly, the genes encoding proteins in the Glutathione Peroxidase 4 ( Gpx4 )-Glutathione (GSH) antioxidant pathway related to ferroptosis susceptibility are impaired upon microglial activation with lipopolysaccharide (LPS) treatment. These results highlight the critical role of P2RY12 in regulating microglial immune and metabolic transcriptional responses under both homeostatic and inflammatory conditions, providing insights into its involvement in CNS pathophysiology. Proposed Model: At basal condition the transcriptional landscape of P2RY12-deficient microglia suggests that the cell is in a highly demanding metabolic state with increased oxidative phosphorylation and glycolysis as well as augmented expression of ribosomal proteins involved in cytoplasmic translation. Additionally, P2RY12-deficient microglia exhibit heightened expression of key regulators of the antioxidant response, suggesting elevated ROS levels as a consequence of this highly metabolically active and energetically demanding microglial state. Elevated ROS levels might diminish microglial antioxidant reserves thus rendering them more vulnerable to additional oxidative stress pushing the redox balance. When activated by LPS treatment, P2RY12-deficient microglia exhibit an impaired responsiveness of system x c and downstream enzymes involved in GSH mediated antioxidant response that together with LPS induced intracellular iron sequestration(François et al., 2014; S. Liu, Gao, & Zhou, 2022; McCarthy et al., 2018; Sfera et al., 2018; Shin et al., 2018; Urrutia et al., 2013) suggesting that P2RY12-deficient microglia will show increased susceptibility to ferroptosis. It is possible that system x c unresponsiveness in KO microglia results from the upregulation of ribosomal proteins involved in the inhibition of MD2, a negative regulator of p53 DNA binding activity(Daftuar, Zhu, Jacq, & Prives, 2013). In this sense, the repression of p53 inhibition will enhance its function, possibly explaining a suppression of Slc7a11 expression in LPS-activated P2RY12 deficient microglia.
- Open Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Microglial cyclooxygenase-1 modulates cerebral capillary basal tone in vivo in mice
Microglia and border associated macrophages have been implicated in hypercapnia, but it is unknown which myeloid cell modulates which vessel type. Previously, we documented in mice myeloid cell association with the brain vasculature but did not distinguish their localization along the vascular tree. Using molecular approaches to distinguish microglia and perivascular macrophages, we show that microglia are the only myeloid cells associating with capillaries. To determine if loss of microglia is sufficient to reduce capillary tone, we employ global and focal ablations and find significant reductions in capillary diameter and red blood cell flux, suggesting vasodilatory regulation by microglia. Cyclooxygenase-1 (COX1), an enzyme with known vasodilatory action, is predominantly expressed by microglia. To determine the necessity of microglial COX1 in regulating cerebral basal capillary tone in vivo, we perform genetic ablation and find a significant reduction in capillary flux and diameter. Together, this study using male mouse models reveals a role for microglial COX1 in maintaining basal capillary tone in vivo.
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Open AccessMicroglial cyclooxygenase-1 modulates cerebral capillary basal tone in vivo in mice
Microglia and border associated macrophages have been implicated in hypercapnia, but it is unknown which myeloid cell modulates which vessel type. Previously, we documented in mice myeloid cell association with the brain vasculature but did not distinguish their localization along the vascular tree. Using molecular approaches to distinguish microglia and perivascular macrophages, we show that microglia are the only myeloid cells associating with capillaries. To determine if loss of microglia is sufficient to reduce capillary tone, we employ global and focal ablations and find significant reductions in capillary diameter and red blood cell flux, suggesting vasodilatory regulation by microglia. Cyclooxygenase-1 (COX1), an enzyme with known vasodilatory action, is predominantly expressed by microglia. To determine the necessity of microglial COX1 in regulating cerebral basal capillary tone in vivo, we perform genetic ablation and find a significant reduction in capillary flux and diameter. Together, this study using male mouse models reveals a role for microglial COX1 in maintaining basal capillary tone in vivo.
- Open Access
- 25 June 2025
- Published by Wiley in Current Protocols
- Vol. 5 (6) , e70167
Two‐Photon Microscopy Functional Assays for Serial Imaging of Brain Microvessels and the Neurovascular Unit Through Disease Progression
Microvascular impairments are a major issue in many diseases of the brain. In fact, they are often considered the earliest pathological phenomena in neurodegenerative diseases like Alzheimer's Disease or the locus of pathology as in stroke. Still, little is known about the mechanistic and cellular level events that contribute to these impairments. Given the importance of the neurovascular unit (NVU) in maintaining functional brain tissue, alterations to NVU cell types are important to study in the context of disease progression. With the use of two‐photon microscopy, microvessels and cells can be imaged and evaluated throughout disease progression. Herein we aim to provide a comprehensive protocol for setting up and using two‐photon microscopy for serial imaging of neurovascular unit cell types (i.e., pericytes, astrocytes, and microglia). We also describe interpreting results from cell and vessel changes based on disease or functional tests through multiple timepoints. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Mouse set up for serial, live 2‐photon imagingBasic Protocol 2: Field of view acquisitions over multiple timepointsBasic Protocol 3: Line scan acquisitions for acquiring red blood cell metricsBasic Protocol 4: Quantitative measurements of vessel and cell changesBasic Protocol 5: Documenting changes in astrocyte morphology following induction of transient focal photothrombotic stroke using Rose Bengal
- 25 June 2025
- Published by Wiley in Current Protocols
- Vol. 5 (6) , e70167
Open AccessTwo‐Photon Microscopy Functional Assays for Serial Imaging of Brain Microvessels and the Neurovascular Unit Through Disease Progression
Microvascular impairments are a major issue in many diseases of the brain. In fact, they are often considered the earliest pathological phenomena in neurodegenerative diseases like Alzheimer's Disease or the locus of pathology as in stroke. Still, little is known about the mechanistic and cellular level events that contribute to these impairments. Given the importance of the neurovascular unit (NVU) in maintaining functional brain tissue, alterations to NVU cell types are important to study in the context of disease progression. With the use of two‐photon microscopy, microvessels and cells can be imaged and evaluated throughout disease progression. Herein we aim to provide a comprehensive protocol for setting up and using two‐photon microscopy for serial imaging of neurovascular unit cell types (i.e., pericytes, astrocytes, and microglia). We also describe interpreting results from cell and vessel changes based on disease or functional tests through multiple timepoints. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Mouse set up for serial, live 2‐photon imagingBasic Protocol 2: Field of view acquisitions over multiple timepointsBasic Protocol 3: Line scan acquisitions for acquiring red blood cell metricsBasic Protocol 4: Quantitative measurements of vessel and cell changesBasic Protocol 5: Documenting changes in astrocyte morphology following induction of transient focal photothrombotic stroke using Rose Bengal